A detailed history of St Germain D J CO Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, St Germain D J CO Inc holds 183 shares of AZN stock, worth $11,759. This represents 0.0% of its overall portfolio holdings.

Number of Shares
183
Previous 140 30.71%
Holding current value
$11,759
Previous $10,000 40.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$76.67 - $87.62 $3,296 - $3,767
43 Added 30.71%
183 $14,000
Q2 2024

Jul 08, 2024

BUY
$66.81 - $80.83 $6,681 - $8,083
100 Added 250.0%
140 $10,000
Q1 2024

Apr 02, 2024

SELL
$61.03 - $69.57 $7,323 - $8,348
-120 Reduced 75.0%
40 $2,000
Q4 2023

Jan 02, 2024

SELL
$61.89 - $69.28 $4,022 - $4,503
-65 Reduced 28.89%
160 $10,000
Q2 2023

Sep 07, 2023

BUY
$69.91 - $75.81 $2,376 - $2,577
34 Added 17.8%
225 $16,000
Q4 2022

Feb 27, 2023

BUY
$54.21 - $70.44 $10,354 - $13,454
191 New
191 $12,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $199B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track St Germain D J CO Inc Portfolio

Follow St Germain D J CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of St Germain D J CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on St Germain D J CO Inc with notifications on news.